Dracula Token (DRC) Price Hits $0.17 on Exchanges | Daily Political
Several other hedge funds and other institutional investors also recently bought and sold shares of G. BlackRock Inc. increased its stake in shares of Genpact by 37.8% during the first quarter. BlackRock Inc. now owns 10,408,378 shares of the business services provider’s stock valued at $445,686,000 after acquiring an additional 2,855,182 shares during the period. Norges Bank acquired a new position in Genpact in the fourth quarter worth approximately $83,531,000. Alliancebernstein L.P. grew its position in Genpact by 17.4% in the first quarter. Alliancebernstein L.P. now owns 6,669,047 shares of the business services provider’s stock worth $285,569,000 after buying an additional 989,107 shares during the last quarter. Victory Capital Management Inc. grew its position in Genpact by 12.2% in the first quarter. Victory Capital Management Inc. now owns 6,917,092 shares of the business services provider’s stock worth $296,190,000 after buying an additional 753,848 shares during the last quarter. Finally, Alyeska Investment Group L.P. acquired a new position in Genpact in the fourth quarter worth approximately $27,837,000. Institutional investors and hedge funds own 98.65% of the company’s stock.
NYSE G opened at $45.55 on Wednesday. Genpact Limited has a twelve month low of $33.91 and a twelve month high of $49.00. The company has a debt-to-equity ratio of 0.94, a quick ratio of 2.03 and a current ratio of 2.03. The stock has a market cap of $8.53 billion, a PE ratio of 28.47, a price-to-earnings-growth ratio of 1.81 and a beta of 1.42. The business’s 50 day moving average price is $45.44.
Genpact (NYSE:G) last issued its earnings results on Monday, May 10th. The business services provider reported $0.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.42 by $0.11. The company had revenue of $946.07 million during the quarter, compared to analyst estimates of $924.57 million. Genpact had a net margin of 8.41% and a return on equity of 20.88%. On average, equities research analysts expect that Genpact Limited will post 1.98 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 23rd. Shareholders of record on Friday, June 11th will be paid a dividend of $0.108 per share. This represents a $0.43 dividend on an annualized basis and a dividend yield of 0.95%. The ex-dividend date of this dividend is Thursday, June 10th. Genpact’s dividend payout ratio (DPR) is currently 23.24%.
In related news, CEO N. V. Tyagarajan sold 70,000 shares of Genpact stock in a transaction on Friday, April 16th. The shares were sold at an average price of $45.01, for a total value of $3,150,700.00. Following the completion of the sale, the chief executive officer now owns 693,765 shares of the company’s stock, valued at approximately $31,226,362.65. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO N. V. Tyagarajan sold 73,625 shares of Genpact stock in a transaction on Tuesday, June 1st. The shares were sold at an average price of $45.75, for a total transaction of $3,368,343.75. Following the completion of the sale, the chief executive officer now directly owns 697,390 shares of the company’s stock, valued at approximately $31,905,592.50. The disclosure for this sale can be found here. Insiders have sold a total of 213,625 shares of company stock valued at $9,638,944 in the last three months. Company insiders own 2.39% of the company’s stock.
Several research analysts have issued reports on the stock. Robert W. Baird restated a “buy” rating and issued a $54.00 price target on shares of Genpact in a research report on Friday, April 23rd. Needham & Company LLC lifted their price target on shares of Genpact from $50.00 to $54.00 and gave the stock a “buy” rating in a research report on Tuesday, May 11th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Genpact presently has a consensus rating of “Buy” and an average target price of $48.80.
Genpact Company Profile
Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. It operates in three segments: Banking, Capital Markets and Insurance; Consumer Goods, Retail, Life Sciences and Healthcare; and High Tech, Manufacturing and Services.
Further Reading: Marijuana Stocks Future Looks Bright
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G).
Receive News & Ratings for Genpact Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Genpact and related companies with MarketBeat.com’s FREE daily email newsletter.
Original Source